88 related articles for article (PubMed ID: 20381105)
1. Serum and intratumoural GH and IGF-I concentrations: prognostic factors in the outcome of canine mammary cancer.
Queiroga FL; Pérez-Alenza D; Silvan G; Peña L; Lopes CS; Illera JC
Res Vet Sci; 2010 Dec; 89(3):396-403. PubMed ID: 20381105
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17beta-estradiol) in canine mammary tumours.
Queiroga FL; Pérez-Alenza MD; Silvan G; Peña L; Lopes CS; Illera JC
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):76-82. PubMed ID: 18367392
[TBL] [Abstract][Full Text] [Related]
3. Treatment of growth hormone excess in dogs with the progesterone receptor antagonist aglépristone.
Bhatti SF; Duchateau L; Okkens AC; Van Ham LM; Mol JA; Kooistra HS
Theriogenology; 2006 Sep; 66(4):797-803. PubMed ID: 16497368
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues.
Mizukami Y; Nonomura A; Yamada T; Kurumaya H; Hayashi M; Koyasaki N; Taniya T; Noguchi M; Nakamura S; Matsubara F
Anticancer Res; 1990; 10(5A):1115-26. PubMed ID: 1978632
[TBL] [Abstract][Full Text] [Related]
5. Serum and Tissue Steroid Hormone Levels in Canine Mammary Tumours: Clinical and Prognostic Implications.
Queiroga FL; Pérez-Alenza D; González-Gil A; Silván G; Peña L; Illera JC
Reprod Domest Anim; 2015 Oct; 50(5):858-65. PubMed ID: 26332137
[TBL] [Abstract][Full Text] [Related]
6. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog.
de Las Mulas JM; Millán Y; Dios R
Vet Pathol; 2005 Mar; 42(2):200-12. PubMed ID: 15753474
[TBL] [Abstract][Full Text] [Related]
7. The growth hormone-insulin-like growth factor axis in glycogen storage disease type 1: evidence of different growth patterns and insulin-like growth factor levels in patients with glycogen storage disease type 1a and 1b.
Melis D; Pivonello R; Parenti G; Della Casa R; Salerno M; Balivo F; Piccolo P; Di Somma C; Colao A; Andria G
J Pediatr; 2010 Apr; 156(4):663-70.e1. PubMed ID: 20022338
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
9. Role of steroid hormones and prolactin in canine mammary cancer.
Queiroga FL; Pérez-Alenza MD; Silvan G; Peña L; Lopes C; Illera JC
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):181-7. PubMed ID: 15862964
[TBL] [Abstract][Full Text] [Related]
10. Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation.
Yang XF; Beamer WG; Huynh H; Pollak M
Cancer Res; 1996 Apr; 56(7):1509-11. PubMed ID: 8603394
[TBL] [Abstract][Full Text] [Related]
11. No association between serum levels of insulin-like growth factor-I, vascular endothelial growth factor, prolactin and clinicopathological characteristics of breast carcinoma after surgery.
Sancak B; Coskun U; Gunel N; Onuk E; Cihan A; Karamercan A; Yildirim Y; Ozkan S
Intern Med J; 2004 Jun; 34(6):310-5. PubMed ID: 15228391
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours.
Queiroga FL; Pérez-Alenza MD; González Gil A; Silvan G; Peña L; Illera JC
Vet Rec; 2014 Oct; 175(16):403. PubMed ID: 25096592
[TBL] [Abstract][Full Text] [Related]
13. Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Milewicz T; Kolodziejczyk J; Krzysiek J; Basta A; Sztefko K; Kurek S; Stachura J; Gregoraszczuk EL
Gynecol Endocrinol; 2002 Aug; 16(4):319-29. PubMed ID: 12396561
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-1 and growth hormone (GH) levels in canine cerebrospinal fluid are unaffected by GH or GH secretagogue (MK-0677) administration.
Prahalada S; Block G; Handt L; DeBurlet G; Cahill M; Hoe CM; van Zwieten MJ
Horm Metab Res; 1999; 31(2-3):133-7. PubMed ID: 10226793
[TBL] [Abstract][Full Text] [Related]
15. Tissue-specific alterations in insulin-like growth factor-I concentrations in response to 3,3',5-triiodo-L-thyronine supplementation in the growth hormone receptor-deficient sex-linked dwarf chicken.
Vasilatos-Younken R; Dunnington EA; Siegel PB; McMurtry JP
Gen Comp Endocrinol; 1997 Jan; 105(1):31-9. PubMed ID: 9000465
[TBL] [Abstract][Full Text] [Related]
16. Role of progestin-induced mammary-derived growth hormone in the pathogenesis of cystic endometrial hyperplasia in the bitch.
Bhatti SF; Rao NA; Okkens AC; Mol JA; Duchateau L; Ducatelle R; van den Ingh TS; Tshamala M; Van Ham LM; Coryn M; Rijnberk A; Kooistra HS
Domest Anim Endocrinol; 2007 Oct; 33(3):294-312. PubMed ID: 16956744
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
Molina R; Farrus B; Filella X; Jo J; Zanón G; Pahisa J; Latre M; Muñoz M; Ballesta AM
Anticancer Res; 1999; 19(4A):2557-62. PubMed ID: 10470194
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.
Rocha RL; Hilsenbeck SG; Jackson JG; VanDenBerg CL; Weng Cn; Lee AV; Yee D
Clin Cancer Res; 1997 Jan; 3(1):103-9. PubMed ID: 9815544
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
20. Quantification of epidermal growth factor receptor (EGFR) in canine mammary tumours by ELISA assay: clinical and prognostic implications.
Queiroga FL; Perez-Alenza MD; González-Gil A; Silván G; Peña L; Illera JC
Vet Comp Oncol; 2017 Jun; 15(2):383-390. PubMed ID: 26463704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]